Apple Joins A.I. Race; Lilly Thumbs-Up on Alzheimer’s Drug
From Nasdaq: 2024-06-10 17:22:00
Market indices closed higher today, with the S&P 500 hitting a new all-time high. Apple made significant A.I. advancements at the WWDC, including a partnership with OpenAI. Unfortunately, Apple’s stock fell 2% after the announcement. Meanwhile, Eli Lilly’s Alzheimer’s drug showed promise in slowing the disease’s progression, pending FDA approval.
In addition, Zacks Investment Research predicts another surge in Bitcoin’s value, citing past presidential election year returns. Download their free report for more details on Bitcoin’s history and potential future growth. They also offer free stock analysis reports for companies like Apple, Biogen, and Eli Lilly. Visit Zacks.com for more information.
Read more at Nasdaq: Apple Joins A.I. Race; Lilly Thumbs-Up on Alzheimer’s Drug